New preprint: a fun collaboration for us on EMCV 2B*, and a first preprint for PhD student @StephenNTD! Work was led by Sam Nguyen and Hazel Stewart from @FirthLab
Come join the lab for a CASE PhD on single-cell proteomics/multiomics! Deadline Jan 15! See the lab website for what we do, and get in touch if any questions!
Fully-funded PhD in my lab available through the @DiMeN_DTP. Advert will be out shortly. Keep an eye out if you are interested in a PhD in studying SARS-CoV-2/coronavirus host interactions, building on our prior data on golga3 cleavage by the virus. https://t.co/98VYfhCTYO
We are hiring! 3 year PDRA position funded by
@The_MRC
using quantitative proteomics (N-terminomics) to study RNA virus-host interactions.
Apply now, further details available at https://t.co/AsaRgRxXz6 job ref 045530. Deadline 10th August.
We are hiring! 3 year PDRA position funded by @The_MRC using quantitative proteomics (N-terminomics) to study RNA virus-host interactions.
Official advert/application not out yet, anyone interested DM/email and I'll forward details once out. Deadline Aug 10th. Please RT!
Small but mighty! This is a video of a killer T cell of the immune system destroying a monstrous ovarian cancer cell. I recently captured this data on a spinning disc confocal microscope.
Funded PhD studentship* between @emmottlab@c4pr_liv and @TrevorSweeney4 at @Pirbright_Inst! Study proteolysis during flavivirus infection!
https://t.co/EReTO0FUlq
*fully funded for UK students, non-UK must be able to make up the difference in international student fees.
If you are interested in hearing more about our work on SARS-CoV-2 proteolysis, or on multiplexed workflows for studying protein N-termini, I'll be giving a webinar on our recent paper on Dec 8th. Thanks @thermosci for the invitation! https://t.co/QQVSux5yXi.
UK-ICN is funded to promote meetings, activities, workshops, movement of Early Career Researchers and other opportunities. These will be through specific calls and open applications. Please join us for the inaugural meeting to find out more.
https://t.co/rY26kUHs5Y #OneHealth
Togo🇹🇬 is first country ever to eliminate "sleeping sickness" as a public health problem! This achievement comes after more than two decades of sustained political commitment, surveillance & screening of cases. Congratulations Togo!
👉🏿https://t.co/LFBSnoe8SC
Just accepted: SARS-CoV-2 has a broader sensitivity to type I and type III interferons
And: Ruxolitinib boosts SARS-CoV-2 replication
Thank you Rune Hartmann and @c_drosten for the great collaboration!
https://t.co/etZH3ceC0W